Salflu HFA 250 Inhaler is a combination medication used for the regular treatment of asthma and chronic obstructive pulmonary disease (COPD). It combines two active ingredients:Arogga
Salmeterol Xinafoate (25 mcg): A long-acting beta-2 adrenergic agonist (LABA) that helps in relaxing the muscles in the airways, making breathing easier.
Fluticasone Propionate (250 mcg): An inhaled corticosteroid that reduces inflammation in the lungs, preventing asthma attacks and flare-ups.
This combination is particularly beneficial for patients who are not adequately controlled with inhaled corticosteroids alone and require a LABA for better symptom management.